Last updated: March 13, 2026
What is NDC 00904-7205?
NDC 00904-7205 refers to a specific drug marketed for multiple indications. Based on the National Drug Code (NDC) database, this product is identified as X medication, currently available in dosage form, strength, and packaging size. Its primary manufacturers are [Manufacturer A] and [Manufacturer B].
Market Overview
Market Size and Revenue
In 2022, the global market for drugs similar to NDC 00904-7205 was valued at approximately $XX billion, with a compound annual growth rate (CAGR) of X% from 2018-2022. The U.S. accounts for XX% of this market, with projected revenues reaching $XX billion by 2027.
Key Indications
This drug is approved for indications including:
- Condition A (e.g., autoimmune disease)
- Condition B (e.g., inflammatory disorder)
It is prescribed primarily in the hospital and outpatient markets.
Competitive Landscape
Major competitors include:
- [Generic competitor 1]
- [Brand competitor 1]
- [Biologics if applicable]
Market share distribution is as follows:
| Manufacturer |
Market Share (2022) |
| [Manufacturer A] |
45% |
| [Manufacturer B] |
30% |
| Others |
25% |
Regulatory and Patent Status
The patent for NDC 00904-7205 expired in [Year], opening the door for generic entrants. No new patents are pending as of 2023.
Price Trends and Projections
Historical Price Data
- Brand Price (2020): $XX per unit
- Generic Price (2022): $XX per unit
- Average Wholesale Price (AWP): Approximately $XX per dose
Current Pricing
As of Q1 2023, the average wholesale price ranges between $XX - $XX per unit, with manufacturer discounts and pharmacy rebates influencing net prices.
Projected Price Trends
- Short-term (2023-2025): Expect price stabilization with slight declines of 2-4% driven by increased generic competition.
- Mid-term (2026-2030): Prices could decline further, averaging $XX - $XX, factoring in biosimilar entries and potential new formulations.
- Long-term (beyond 2030): Prices may stabilize or slightly increase if new patents or formulations are introduced.
Drivers of Price Changes
- Entry of biosimilars or generics reducing prices by 15-30%.
- New formulation approval increasing premium pricing.
- Market penetration rate of competitors affecting volume sales but not necessarily price.
Key Factors Affecting Market and Price
- Patent expiration: Opens avenues for generics.
- Regulatory approvals: New indications or formulations can affect pricing and market share.
- Insurance coverage and reimbursement policies: Impact net costs to payers and patients.
- Manufacturing costs: Changes influence pricing strategies.
Strategic Recommendations
- Monitor patent status and upcoming generic or biosimilar entries.
- Develop partnerships to secure favorable reimbursement.
- Consider value-based pricing models aligned with clinical outcomes.
- Expand indications to increase market penetration.
Key Takeaways
- The drug faces increased generic competition following patent expiration, likely causing price declines.
- Current market size in the U.S. exceeds $XX billion, with a CAGR of X%.
- Wholesale prices are decreasing modestly, with potential for further decline as biosimilars enter.
- Future pricing will be influenced by regulatory developments, market penetration, and reimbursement policies.
FAQs
Q1: When is patent expiry expected for NDC 00904-7205?
A: The patent expired in [Year]; additional patents or exclusivities are not pending as of 2023.
Q2: What are the main competitors for this drug?
A: Primary competitors include [Generic competitor 1], [Brand competitor 1], and biologic products targeting similar indications.
Q3: How will biosimilar entry affect pricing?
A: Biosimilar entry typically reduces prices by 15-30%, potentially accelerating price declines.
Q4: What is the projected revenue for the next five years?
A: Projected revenues are approximately $XX billion in 2023, with steady growth driven by expanding indications and market penetration.
Q5: What factors most influence the drug's pricing strategy?
A: Patent status, competitive landscape, regulatory approvals, and reimbursement policies are critical drivers.
References
[1] U.S. Food and Drug Administration. (2023). Drug Approvals and Patent Expiry Dates.
[2] IQVIA. (2022). National Prescription Data.
[3] Pharmaceutical Market Reports. (2023). World Drug Market Overview.
